Lee Chiang W, Lee Song F, Halperin Scott A
Department of Applied Oral Sciences, Faculty of Dentistry, Dalhousie University, Halifax, Nova Scotia B3H 3J5, Canada.
Appl Environ Microbiol. 2004 Aug;70(8):4569-74. doi: 10.1128/AEM.70.8.4569-4574.2004.
A nontoxic mutant diphtheria toxin fragment A (DTA) was genetically fused in single, double, or triple copy to the major surface protein antigen P1 (SpaP) and surface expressed in Streptococcus gordonii DL-1. The expression was verified by Western immunoblotting. Mouse antisera raised against the recombinant S. gordonii recognized the native diphtheria toxinm suggesting the recombinant DTA was immunogenic. When given intranasally to mice with cholera toxin subunit B as the adjuvant, the recombinant S. gordonii expressing double copies of DTA (SpaP-DTA(2)) induced a mucosal immunoglobulin A response and a weak systemic immunoglobulin G response. S. gordonii SpaP-DTA(2) was able to orally colonize BALB/c mice for a 15-week period and elicited a mucosal response, but a serum immunoglobulin G response was not apparent. The antisera failed to neutralize diphtheria toxin cytotoxicity in a Vero cell assay.
一种无毒的突变白喉毒素片段A(DTA)以单拷贝、双拷贝或三拷贝的形式与主要表面蛋白抗原P1(SpaP)进行基因融合,并在戈登链球菌DL-1中进行表面表达。通过蛋白质免疫印迹法验证了其表达。用针对重组戈登链球菌的小鼠抗血清识别天然白喉毒素,表明重组DTA具有免疫原性。当以霍乱毒素B亚基作为佐剂经鼻给予小鼠时,表达双拷贝DTA的重组戈登链球菌(SpaP-DTA(2))诱导了黏膜免疫球蛋白A反应和较弱的全身免疫球蛋白G反应。戈登链球菌SpaP-DTA(2)能够在BALB/c小鼠肠道内定殖15周并引发黏膜反应,但血清免疫球蛋白G反应不明显。在Vero细胞试验中,该抗血清未能中和白喉毒素的细胞毒性。